Website Header with Language Selector and Dropdowns

Imipramine Hydrochloride EP Impurity B


Catalog Number: CL-IMIP-03
CAS No.: 315-69-5
Mol.F: C20H24N2
Mol.W: 292.4
Inv. Status: Custom Synthesis

Chemical Name: 3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride .

Country of Origin: India

Product Category: Imipramine Impurities


Imipramine Hydrochloride EP Impurity B is identified by CAS No. 315-69-5 and is chemically known as 3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride .

Imipramine Hydrochloride EP Impurity B is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Imipramine.

Page Keywords: Buy Imipramine Hydrochloride EP Impurity B | Purchase Imipramine Hydrochloride EP Impurity B | Imipramine Hydrochloride EP Impurity B suppliers | Imipramine Hydrochloride EP Impurity B manufacturers | Imipramine Hydrochloride EP Impurity B price | Imipramine Hydrochloride EP Impurity B Importer | Imipramine Hydrochloride EP Impurity B Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-IMIP-06
CAS No: 50-47-5
Mol Wt: 266.4
Mol F: C18H22N2
Inv. Status: In Stock
CAT No: CL-IMIP-01
CAS No: 14171-70-1
Mol Wt: 310.4
Mol F: C20H26N2O
Inv. Status: Custom Synthesis
CAT No: CL-IMIP-02
CAS No: 2293-21-2
Mol Wt: 280.4
Mol F: C19H24N2
Inv. Status: Custom Synthesis
CAT No: CL-IMIP-04
CAS No: 50-49-7
Mol Wt: 280.4
Mol F: C19H24N2
Inv. Status: Custom Synthesis
CAT No: CL-IMIP-07
CAS No: NA
Mol Wt: 359.3 : 98.1
Mol F: C19H23BrN2 : H2SO4
Inv. Status: Custom Synthesis
CAT No: CL-IMIP-05
CAS No: NA
Mol Wt: 296.41
Mol F: C19H24N2O
Inv. Status: In Stock
CAT No: CL-IMIP-08
CAS No: 10075-24-8
Mol Wt: 2(280.4) : 388.4
Mol F: 2(C19H24N2 ): C23H16O6
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.